Ligand validation:3SWQ

EPU: URIDINE-DIPHOSPHATE-2(N-ACETYLGLUCOSAMINYL) BUTYRIC ACID

EPU is a Ligand Of Interest in 3SWQ designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
3SWQ_EPU_A_440	96%	21%	0.067	0.978	1.73	1.57	9	7	0	0	100%	1
1RYW_EPU_D_5450	89%	21%	0.103	0.982	1.93	1.39	18	10	1	0	100%	1
5BQ2_EPU_D_501	96%	37%	0.072	0.979	1.39	1.09	6	4	0	0	100%	1
6Q11_EPU_A_501	88%	35%	0.097	0.971	1.11	1.45	4	10	1	0	100%	0.5
5WI5_EPU_A_503	86%	27%	0.109	0.978	1.18	1.72	4	10	0	0	100%	1
1P31_EPU_B_602	84%	31%	0.105	0.968	1.18	1.56	6	9	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.